Lindsay Androski
Director, Eloxx Pharmaceuticals, Inc.
Companies
- Arbutus BiopharmaBoard member Mar 6, 2025 to now1
- Arbutus BiopharmaChief executive officer Mar 6, 2025 to now1
- Arbutus BiopharmaPresident Mar 6, 2025 to now1
- Eloxx Pharmaceuticals, Inc.Board member Jul 6, 2022 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Arbutus Biopharma ABUS72,337 shares3$310.0K at $4.29Sep 18, 2026- Eloxx Pharmaceuticals, Inc. ELOX15,750 shares4$196.7K at $12.49Jan 24, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 18, 2026Shares withheld for tax 82,527 shares at $5.07 of Arbutus Biopharma3
- Sep 18, 2026Exercised options 10,456 shares at $4.39 of Arbutus Biopharma3
- Sep 18, 2026Exercised options 116,408 shares at $3.20 of Arbutus Biopharma3
- Feb 2, 2026Granted 28,000 shares of Arbutus Biopharma5
- Jan 24, 2025Exercised options 3,750 shares of Eloxx Pharmaceuticals, Inc.4
- Oct 16, 2024Granted 12,000 shares of Eloxx Pharmaceuticals, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARArbutus Biopharma, Board member
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Feb 2, 2026
- 6SEC EDGARForm 4 filed Oct 17, 2024